SRI International is a nonprofit, independent research center serving government and industry. We work on some of the world’s most important problems, collaborating across technical disciplines to spark new ideas and solutions. Our research and innovations have led to new industries and products that impact people’s lives every day—from the computer mouse and interactive computing to medical ultrasound, cancer drugs, and much more.
twoXAR Pharmaceuticals has built a development portfolio targeting 18+ different diseases. twoXAR’s unique approach to drug discovery combines steps from the traditional multi-step approach to R&D that severely limits the pace of drug discovery. This novel method – coupled with the company’s proprietary AI-driven platform – enables twoXAR to select a disease and initiate in vivo testing in months, instead of years.